Inventor · disambiguated record
Nikole Sandy
Also filed as: Sandy Nikole
7 granted patents·8 pending applications·217 citations·filing 2016–2024
87Inventor score
Top patents by PatentIndex Score
15 records- 0197US9617338B1Antibodies and immunocytokinesKYMAB LTD·Filed 2016·Granted Apr 11, 2017·78 cites·20 claims
- 0297US9567399B1Antibodies and immunocytokinesKYMAB LTD·Filed 2016·Granted Feb 14, 2017·96 cites·21 claims
- 0396US9957323B2Anti-ICOS antibodiesKYMAB LTD·Filed 2017·Granted May 1, 2018·27 cites·26 claims
- 0489US11214620B2Binding molecules binding PD-L1 and LAG-3F STAR DELTA LTD·Filed 2017·Granted Jan 4, 2022·11 cites·20 claims
- 0588US12209128B2Anti-PD-L1 antibodiesKYMAB LTD·Filed 2021·Granted Jan 28, 2025·1 cites·6 claims
- 0688US11965026B2Anti-PD-L1 and IL-2 cytokinesKYMAB LTD·Filed 2017·Granted Apr 23, 2024·3 cites·19 claims
- 0783US2024360218A1Anti-pd-l1 and il-2 cytokinesKYMAB LTD·Filed 2024·Application pending·0 cites
- 0883US2024343810A1Multispecific antibodies for immuno-oncologyKYMAB LTD·Filed 2024·Application pending·0 cites
- 0977US2022380467A1Anti-icos antibodiesKYMAB LTD·Filed 2022·Application pending·0 cites
- 1077US2022403029A1Anti-icos antibodiesKYMAB LTD·Filed 2022·Application pending·0 cites
- 1177US2023312720A1Multispecific antibodies for immuno-oncologyKYMAB LTD·Filed 2022·Application pending·0 cites
- 1275US11440960B2TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivoKYMAB LTD·Filed 2018·Granted Sep 13, 2022·1 cites·14 claims
- 1370US2023192847A1Tigit antibodies, encoding nucleic acids and methods of using said antibodies in vivoKYMAB LTD·Filed 2022·Application pending·0 cites
- 1461US2022185894A1Binding molecules binding pd-l1 and lag-3F STAR THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1556US2020190191A1Multispecific antibody with combination therapy for immuno-oncologyKYMAB LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nikole Sandy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →